Agile Therapeutics Reports Third Quarter Financial Results
09 nov. 2015 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
The Population Council and WomanCare Global Announce Worldwide License Agreement to Advance Women's Access to Innovative Contraceptive Ring
04 nov. 2015 09h15 HE
|
WomanCare Global
NEW YORK and SAN DIEGO, Nov. 4, 2015 (GLOBE NEWSWIRE) -- In a major step forward for women's health, the Population Council and WomanCare Global (WCG) today announced an exclusive worldwide licensing...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
19 oct. 2015 16h08 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
03 sept. 2015 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
31 août 2015 16h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
EWTN Denied Protection Against Contraception Mandate
17 juin 2014 20h15 HE
|
EWTN Global Catholic Network
Irondale, AL, June 17, 2014 (GLOBE NEWSWIRE) -- U.S. District Court Judge Callie V.S. Granade of Mobile, Ala.
issued an opinion on June 17 denying EWTN Global Catholic Network
protection from the...
Conceptus, Inc. Acquisition Investigation
29 avr. 2013 13h12 HE
|
WeissLaw LLP
NEW YORK, April 29, 2013 (GLOBE NEWSWIRE) -- WeissLaw LLP, a national class action, shareholder rights law firm with offices in New York and Los Angeles, is examining possible breaches of fiduciary...
Keller Rohrback L.L.P. Announces Investigation of Harmful Side Effects Associated With Beyaz, Safyral, Yasmin, and Yaz Birth Control Pills
13 avr. 2012 14h09 HE
|
Keller Rohrback L.L.P.
SEATTLE, April 13, 2012 (GLOBE NEWSWIRE) -- Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com/investigations/beyaz-safyral-yasmin-and-yaz-birth-control-pills">www.krcomplexlit.com)...
CA Dept. of Health Services Announces New Gyn Benefit for California's Neediest Women
08 juil. 2008 20h56 HE
|
EASy Gyn
SAN JOSE, CA--(Marketwire - July 8, 2008) - Following Medi-Cal, which added in-office
hysteroscopic sterilization as a covered benefit in May, the State Office
of Family Planning today announced ...